美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Faeth Therapeutics

24.54

+0.54002.25%

盤後：24.540.00000.00%16:10 EDT

成交量：10.28萬

成交額：265.54萬

市值：6.33億

市盈率：-0.17

高：27.77

開：24.05

低：24.05

收：24.00

52周最高：36.76

52周最低：6.33

股本：2,577.88萬

流通股本：81.17萬

量比：0.81

換手率：12.67%

股息：- -

股息率：- -

每股收益(TTM):-142.7282

每股收益(LYR):-16.7239

淨資產收益率：--

總資產收益率：-95.24%

市淨率：-4.61

市盈率(LYR):-1.47

資料載入中...

總覽公司新聞公告

Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布

Sensei Biotherapeutics：Piktor治療晚期子宮內膜癌的II期關鍵數據預計2026年下半年公布

Sensei Biotherapeutics任命Anand Parikh為董事長、總裁兼首席執行官，自2026年6月12日起生效

Sensei Biotherapeutics更名為Faeth Therapeutics，全力推進口服抗癌療法Piktor

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/FTH/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":24.54,"timestamp":1782331200000,"preClose":24,"halted":0,"volume":102819,"hourTrading":{"tag":"盘后","latestPrice":24.54,"preClose":24.54,"latestTime":"16:10 EDT","volume":386,"amount":9472.44,"timestamp":1782331805188,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.022499999999999964,"floatShares":811700,"shares":25778800,"eps":-142.7282,"marketStatus":"盤後交易","change":0.54,"latestTime":"06-24 16:53:25 EDT","open":24.05,"high":27.77,"low":24.05,"amount":2655382,"amplitude":0.155,"askPrice":28.8,"askSize":70,"bidPrice":24,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-142.7282,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1782345600000},"marketStatusCode":4,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":24,"preHourTrading":{"tag":"盘前","latestPrice":23.11,"preClose":24,"latestTime":"09:22 EDT","volume":56,"amount":1337.459928,"timestamp":1782307368421,"change":-0.89,"changeRate":-0.037083,"amplitude":0.037083},"postHourTrading":{"tag":"盘后","latestPrice":24.54,"preClose":24.54,"latestTime":"16:10 EDT","volume":386,"amount":9472.44,"timestamp":1782331805188,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.814321},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-95.24%","roe":"--","lyrEps":-16.72388,"volumeRatio":0.814321,"shares":25778800,"dividePrice":0,"high":27.77,"amplitude":0.155,"preClose":24,"low":24.05,"week52Low":6.325,"pbRate":"-4.61","week52High":36.76,"institutionHeld":0,"latestPrice":24.54,"committee":-0.75,"eps":-142.7282,"divideRate":0,"volume":102819,"delay":0,"ttmEps":-142.7282,"open":24.05,"prevYearClose":10.67,"prevWeekClose":17.82,"prevMonthClose":21.14,"prevQuarterClose":31.52,"fiveDayClose":14.53,"twentyDayClose":16.47,"sixtyDayClose":27.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91},{"market":"US","date":"2025-06-17","symbol":"FTH","defaultRemindTime":1750167000000,"type":"split","dateTimestamp":1750132800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-06-23","current":-0.171935,"percent":0,"low":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"high":-0.105707,"avg":-0.131297,"sd":0.023241,"marketCap":31119611},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-23","current":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"marketCap":31119611}],"updateTime":1782334403867},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155638133","title":"Sensei Biotherapeutics：Piktor治療HR+/HER2-晚期乳腺癌的1B/2期中期數據預計2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155638133?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据，预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197135575","title":"Sensei Biotherapeutics：Piktor治療晚期子宮內膜癌的II期關鍵數據預計2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197135575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197135575?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布，其候选药物Piktor针对晚期子宫内膜癌的II期临床试验关键性数据，预计将于2026年下半年公布。这一时间表为关注该疗法进展的投资者和医学界提供了明确的时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110665123","title":"Sensei Biotherapeutics任命Anand Parikh為董事長、總裁兼首席執行官，自2026年6月12日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110665123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110665123?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:11","pubTimestamp":1781525508,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. (SNSE) 宣布，自2026年6月12日起，Anand Parikh将正式出任公司董事长、总裁兼首席执行官。此项任命标志着公司领导层的重要更迭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139331227","title":"Sensei Biotherapeutics更名為Faeth Therapeutics，全力推進口服抗癌療法Piktor","url":"https://stock-news.laohu8.com/highlight/detail?id=1139331227","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139331227?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 20:10","pubTimestamp":1781525426,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. 宣布将公司名称变更为Faeth Therapeutics。这一更名标志着公司战略重心聚焦于推进其核心候选药物Piktor的研发。Piktor是一种口服疗法，旨在靶向癌症中最常发生异常改变的信号通路之一。公司此举旨在更好地反映其专注于开发变革性癌症治疗药物的新方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}